Non-inferiority trials using a surrogate marker as the primary endpoint: An increasing phenotype in cardiovascular trials. uri icon

authors

  • Bikdeli, Behnood
  • Caraballo, César
  • Welsh, John
  • Joseph S. Ross, MD, MHS
  • Kaul, Sanjay
  • Stone, Gregg W
  • Krumholz, Harlan M

publication date

  • January 1, 2020